A validated lab method measures CBD in nanoformulations and cell media
Validated QuEChERS-HPLC-UV Method for Quantification of Cannabidiol in Pharmaceutical Nanoformulations.
AI Summary
This study asked whether a validated QuEChERS extraction and HPLC-UV method could reliably measure CBD in pharmaceutical nanoformulations and in cell-assay medium. Testing was performed on representative samples of CBD-loaded lipid nanoparticle powder and Dulbecco’s modified Eagle medium—not in people or animals. The method showed strong linearity, low matrix effects, recoveries above 90%, and reported precision within the abstract’s stated limits.
The researchers applied the method to stability testing of nanoformulated products containing 3% and 5% CBD; the abstract reports that 25 °C was the optimal storage temperature over six months. In a separate cellular uptake study, nanoformulated CBD had higher uptake than isolate and oil-based forms. These findings concern analytical measurement, product stability, and cellular uptake; they do not establish a health benefit or improved effects in humans. This is an abstract-based summary: the abstract does not provide the uptake study’s model details or enough information to assess the broader limits of the experiments.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More CBD research papers you might find interesting.
A lab method measures 17 cannabinoids across five hemp product types
CBD showed limited adaptive-functioning differences versus placebo in boys…
NMR profiling finds THC predominates in Moroccan beldia extracts
Explore More Research
Stay informed about the latest cannabis science.